| abstract |
The present invention relates to a compound (I) capable of inhibiting Mst1 / 2 protein kinase activity, a method for producing the same, a pharmaceutical composition comprising the compound, and a method for promoting the treatment and regeneration of tissues and organs and for stem cell proliferation and somatic cell depletion , Immunosuppression, and the use of such compounds and pharmaceutical compositions comprising such compounds in the manufacture of a medicament for the prevention or treatment of diseases associated with neurological disorders and local ischemia. |